NCT06753149View on ClinicalTrials.gov

Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke

Not yet recruitingOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Ischemic StrokeTIA (Transient Ischemic Attack)Clopidogrel Resistance

All Listed Sponsors

lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT06753149 - Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke | Biotech Hunter | Biotech Hunter